![]() |
|
|
Vol. 297, Issue 3, 906-914, June 2001
Institute for Biological Sciences, National Research Council of
Canada, Ottawa, Ontario, Canada (G.A.R.M., D.L.S., T.M.C., P.M.); and
AstraZeneca R&D Boston, Worcester, Massachusetts (T.H.L., R.J.M.,
K.C.M.)
Differences in the degree of trapping of initial block by
N-methyl-D-aspartate (NMDA) receptor
antagonists may affect their safety and, hence, suitability for
clinical trials. In this comparative study, 23 compounds structurally
related to the low-affinity, use-dependent NMDA receptor antagonist
(S)-
-phenyl-2-pyridineethanamine dihydrochloride
(AR-R15896AR) were examined to determine the degree of trapping block
they exhibit. Compounds were tested at concentrations that produced a
comparable initial 80% block of NMDA-mediated whole-cell current in
rat cortical cultures. A wide range of values of trapping block was
found, indicating that trapping is not an all-or-none event. Fifteen of
the compounds trapped significantly more than the 54 ± 3% of
initial block trapped by AR-R15896AR. The off-rates of these compounds
were slower than that of AR-R15896AR. Only 2 of the 23 compounds
trapped significantly less than AR-R15896AR. AR-R15808, the piperidine
analog of AR-R15896AR, appeared to trap only 8 ± 3% of its
initial block, although its fast off-rate confounded accurate
quantification of trapping. AR-R26952, which, like AR-R15896AR, contains a pyridine in place of a phenyl group, trapped 40 ± 5% of its initial block and exhibited kinetics comparable with
AR-R15896AR. Structure-activity analysis suggested that the presence of
two basic nitrogen atoms and decreased hydrophobicity led to decreased trapping. There was no correlation between trapping and lipophilicity as would be expected if closed-channel egress was due to escape through
the lipid bilayer. However, there was a positive correlation between
off-rate and degree of trapping. Models that can account for partial
trapping are presented.
This article has been cited by other articles:
![]() |
S. X. Jiang, J. Lertvorachon, S. T. Hou, Y. Konishi, J. Webster, G. Mealing, E. Brunette, J. Tauskela, and E. Preston Chlortetracycline and Demeclocycline Inhibit Calpains and Protect Mouse Neurons against Glutamate Toxicity and Cerebral Ischemia J. Biol. Chem., October 7, 2005; 280(40): 33811 - 33818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Petrovic, M. Sedlacek, M. Horak, H. Chodounska, and L. Vyklicky Jr 20-Oxo-5{beta}-Pregnan-3{alpha}-yl Sulfate Is a Use-Dependent NMDA Receptor Inhibitor J. Neurosci., September 14, 2005; 25(37): 8439 - 8450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. V. Chen and S. A. Lipton Pharmacological Implications of Two Distinct Mechanisms of Interaction of Memantine with N-Methyl-D-aspartate-Gated Channels J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 961 - 971. [Abstract] [Full Text] [PDF] |
||||